Helix Acquisition Corp. III Prices $150 Million IPO
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 14h ago
0mins
Source: NASDAQ.COM
- IPO Pricing: Helix Acquisition Corp. III has priced its initial public offering of 15 million Class A ordinary shares at $10 per share, successfully raising $150 million to fund future business combinations.
- Exchange Listing: The offering is expected to close on January 26, with shares set to begin trading on the Nasdaq Global Market under the ticker symbol 'HLXC', marking the company's official entry into the capital markets.
- Over-Allotment Option: Underwriters have been granted a 45-day option to purchase an additional 2.25 million Class A ordinary shares to cover over-allotments, which will enhance the company's financial flexibility.
- Industry Focus: As a special purpose acquisition company, Helix Acquisition Corp. III is focused on pursuing business combinations in the healthcare or healthcare-related industries, indicating its strategic positioning in the rapidly evolving healthcare market.
Analyst Views on HLXC
Wall Street analysts forecast HLXC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for HLXC is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Analyst Rating
0 Buy
0 Hold
0 Sell
Current: 10.000
Low
Averages
High
Current: 10.000
Low
Averages
High
No data
About HLXC
Helix Acquisition Corp III located in Boston, Massachusetts is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
